Risk Factors Evaluation and Antiviral Eradication Therapies Among HCV Infected Family Members of Northern Regions, Pakistan

Authors

  • Ikram Ulllah Abbottabad University of Science and Technology, Havelian, KPK, 22502, Pakistan
  • Mashhood Ali Department of Gastroenterology, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
  • Hamza Altaf Department of Microbiology, Quaid-i-Azam University, Islamabad, 45320, Pakistan
  • Shahid Aziz Institute of Allied Health Sciences, Pakistan Ordinance Factories, Rawalpindi, Pakistan
  • Salamat Ali Department of Pharmacy Practice, Government College University, Faisalabad, Pakistan
  • Ghulam Mustafa Institute of Allied Health Sciences, Pakistan Ordinance Factories, Rawalpindi, Pakistan
  • Ali Akbar Centre for Biotechnology and Microbiology, University of Swat, KPK, Pakistan
  • Muhammad Ayub Jadoon Abbottabad University of Science and Technology, Havelian, KPK, 22502, Pakistan
  • Faisal Rasheed Patients Diagnostic Lab, IAD, PINSTECH, Nilore, Islamabad, 45650, Pakistan

DOI:

https://doi.org/10.53560/PPASB(62-1)1057

Keywords:

Intrafamilial Transmission, Household Subjects, Genotype, Therapeutic Regimens

Abstract

Hepatitis C virus (HCV) poses a global health threat, often transmitted intra-familial. This study aims to assess HCV transmission within Pakistani households and identify associated risk factors. To analyze 125 household subjects for HCV infection prevalence, demographics, genotypes, and risk factors. We conducted a comprehensive analysis of 125 household subjects to determine HCV prevalence. Demographics, genotypes, and risk factors were carefully examined through rigorous data collection and statistical analysis. Of the 125 households surveyed, 57 tested positive for HCV, indicating a high prevalence rate. Within these households, 121 individuals were infected, with a slightly higher proportion of females (59.5%). The distribution of infections varied across regions, with Islamabad showing the highest prevalence at 56.14%. Among the infected individuals, offspring were significantly affected (42.1%), followed by spouses (29.8%) and siblings (28%). Genotype 3a emerged as the most prevalent strain. Risk factors contributing to intra-familial transmission included major surgeries, dental procedures, hospitalizations, and blood transfusions. Furthermore, sharing personal items such as blades and towels also posed significant risks. Intra-familial transmission is a key driver of HCV spread within Pakistani households. The study's findings underscore the urgent need for targeted interventions to control and prevent HCV transmission within familial settings. Strategies should focus on raising awareness about risk factors and promoting preventive practices. Additionally, The most effective outcomes in the current study were observed with the combination therapy of Sofosbuvir and Ribavirin, achieving an End of Treatment Response (ETR) of 73% and a Sustained Virologic Response (SVR) of 72%.

References

Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362 (1989).

P. Simmonds. Genetic diversity and evolution of hepatitis C virus–15 years on. Journal of General Virology 85(11): 3173-3188 (2004).

W. Qin, T. Yamashita, Y. Shirota, Y. Lin, W. Wei, and S. Murakami. Mutational analysis of the structure and functions of hepatitis C virus RNA–dependent RNA polymerase. Hepatology 33(3): 728-737 (2001).

C. Luca, L. Grigore, A. Vâţă, and C. Dorobăţ. Adverse reactions of different treatments in chronic hepatitis C. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 113(4): 991-995 (2009).

F. Penin, J. Dubuisson, F.A. Rey, D. Moradpour, and J.M. Pawlotsky. Structural biology of hepatitis C virus. Hepatology 39(1): 5-19 (2004).

N.N. Zein, J. Rakela, E.L. Krawitt, K.R. Reddy, T. Tominaga, and D.H. Persing. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. Annals of Internal Medicine 125(8): 634-639 (1996).

M. Liew, M. Erali, S. Page, D. Hillyard, and C. Wittwer. Hepatitis C genotyping by denaturing high-performance liquid chromatography. Journal of Clinical Microbiology 42(1): 158-163 (2004).

E. Chak, A.H. Talal, K.E. Sherman, E.R. Schiff, and S. Saab. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver International 31(8): 1090-1101 (2011).

M.G. Ghany, D.B. Strader, D.L. Thomas, and L.B. Seeff. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49(4): 1335-1374 (2009).

A. Fani, I. Fani, B. Eshratie, P. Samadian, P. Fan, G. Iaser, and M, Fateneh. Screening for hepatocellular carcinoma chronic in hepatitis B and C carriers in Markazi Province, Iran. Hepatitis Monthly 7(3): 149-152 (2007).

S. Hamid, M. Umar, A. Alam, A. Siddiqui, H. Qureshi, and J. Butt. PSG consensus statement on management of hepatitis C virus infection--2003. The Journal of the Pakistan Medical Association 54(3): 146-150 (2004).

P.S. Rice, D.B. Smith, P. Simmond, and E. Holmes. Heterosexual transmission of hepatitis C virus. Lancet 342(8878): 1052-1053 (1993).

S.J. Skidmore, K.E. Collingham, and S.M. Drake. Brief report: sexual transmission of hepatitis C. Journal of Medical Virology 42(3): 247-248 (1994).

C. Mazzeo, F. Azzaroli, S. Giovanelli, A. Dormi, D. Festi, A. Colecchia, A. Miracolo, P. Natale, G. Nigro, A. Alberti, and E. Roda. Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut 52(7) 1030-1034 (2003).

S.W. Chan, F. McOmish, E. Holmes, B. Dow, J.F Peutherer, E. Follett, P.L Yap, and P. Simmonds. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. Journal of General Virology 73(5): 1131-1141 (1992).

N.D.P. Cavalheiro. Hepatitis C: transmission between couples. Tese de Doutorado - Faculdade de Medicina da Universidade de São Paulo, Brazil (2004). https://doi.org/10.1590/S0036-46652004000200016

N.D.P. Cavalheiro, A.D.L. Rosa, S. Elagin, F.M. Tengan, E.S.A.D. Araújo, and A.A Barone. Hepatitis C: sexual or intrafamilial transmission? Epidemiological and phylogenetic analysis of hepatitis C virus in 24 infected couples. Revista da Sociedade Brasileira de Medicina Tropical 42: 239-244 (2009).

G.M. Lauer and B.D. Walker. Hepatitis C virus infection. New England Journal of Medicine 345(1): 41-52 (2001).

D.R. Gretch, C. dela Rosa, R.L. Carithers Jr, R.A. Willson, B. Williams, and L. Corey. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Annals of Internal Medicine 123(5): 321-329 (1995).

S.S. Richter. Laboratory assays for diagnosis and management of hepatitis C virus infection. Journal of Clinical Microbiology 41(1): 530-530 (2003).

C.E. Samuel. Antiviral actions of interferons. Clinical Microbiology Reviews 14(4): 778-809 (2001).

H.S. Te, G. Randall, and D.M. Jensen. Mechanism of action of ribavirin in the treatment of chronic hepatitis C. Gastroenterology & Hepatology 3(3): 218 (2007).

M.P. Walker and Z. Hong. HCV RNA-dependent RNA polymerase as a target for antiviral development. Current Opinion in Pharmacology 2(5): 534-540 (2002).

S. Khan, M.A. Rai, A. Khan, A. Farooqui, S.U. Kazmi, and S.H Ali. Prevalence of HCV and HIV infections in 2005-Earthquake-affected areas of Pakistan. BMC Infectious Diseases 8: 147 (2008).

M. Umer, and M. Iqbal. Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data. World Journal of Gastroenterology 22(4): 1684 (2016).

G. Idéo, G. Bellati, E. Pedraglio, R. Bottelli, T. Donzelli, and G. Putignano. Intrafamilial transmission of hepatitis C virus. Lancet 335: 353 (1990).

M. Perez-Romero, A. Sanchez-Quijano, and E. Lissen. Transmission of hepatitis C virus. Annals of Internal Medicine 113(5): 411-412 (1990).

S. Akhtar, T. Moatter, S. Azam, M.H. Rahbar, and S. Adil. Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan. Journal of Viral Hepatitis 9(4): 309-314 (2002).

S. Luby, K. Qamruddin, A. Shah, A. Omair, O. Pahsa, A.J. Khan, J.B. McCormick, F. Hoodbhouy, and S. Fisher-Hoch. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiology & Infection 119(3): 349-356 (1997).

S. Akhtar and T. Moatter. Intra-household clustering of hepatitis C virus infection in Karachi, Pakistan. Transactions of The Royal Society of Tropical Medicine and Hygiene 98(9): 535-539 (2004).

M.A. Qazi, M. Fayyaz, G. Chaudhary, A. Amil, A.H. Malik, A.I. Gardezi, and M.H. Bukhari. Hepatitis C virus genotypes in Bahawalpur. Biomedica 22(1): 51-4 (2006).

A. Galli and J. Bukh. Comparative analysis of the molecular mechanisms of recombination in hepatitis C virus. Trends in Microbiology 22(6): 354-364 (2014).

Published

2025-03-04

How to Cite

Ulllah, I., Ali, M., Altaf, H., Aziz, S., Ali, S., Mustafa, G., Akbar, A., Jadoon, M. A., & Rasheed, F. (2025). Risk Factors Evaluation and Antiviral Eradication Therapies Among HCV Infected Family Members of Northern Regions, Pakistan. Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences, 62(1). https://doi.org/10.53560/PPASB(62-1)1057

Issue

Vol. 62 No. 1 (2025)

Section

Research Articles

License

Copyright (c) 2025 Upon acceptance of an article, its copyright will be assigned to the Pakistan Academy of Sciences.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons Attribution (CC BY). Allows users to: copy the article and distribute; abstracts, create extracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: includes a link to the license; indicates if changes were made; gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); and does not represent the author(s) as endorsing the adaptation of the article or modify the article in such a way as to damage the authors' honor or reputation.